Loading
Total declarations
Companies
▲ Purchases (527 ops.)
▼ Sales (99 ops.)
Latest filing published 14 Mar 2012 for Ocera Therapeutics, Inc., €618.
Filing timeline
BuySale14159 capital (GP), LLC
First 200 filings with a declared amount
Insider track record
Disclosed buys
527
Disclosed sells
99
Signal history
No signal scores available.
Closed purchases
Market purchases
527
Positive at T+90
68%
Median T+90
+22.7%
Based on 80 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +7.8%Entry US$17.79 · Close at T+365 US$19.18
- +25.3%Entry US$13.20 · Close at T+365 US$16.54
- +33.5%Entry US$13.60 · Close at T+365 US$18.16
- +25.4%Entry US$13.96 · Close at T+365 US$17.50
- +484.9%Entry US$2.05 · Close at T+365 US$11.99
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
14159 capital (GP), LLC: trading record in brief
This profile gathers the share dealings of 14159 capital (GP), LLC across 14 companies, led by Genomic Health Inc, Incyte Corp and Seagen Inc. In total, 635 filings cover trades dated from 24 February 2006 to 14 March 2012.
In open-market terms, that means 527 purchases worth €14.3M on one side and 99 sales worth €3.8M on the other. Taken together, the purchases exceed the sales by €10.5M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 7 share grants. 2012 to date brings 53 purchases and no sales.
The median purchase comes to €9,673. Looking at 80 purchases old enough to measure, the stock rose over the following 90 days in 68% of cases; the median change was +22.7%. They describe history only and say nothing certain about the share price ahead.
Most recently, on 14 March 2012, the filings show an open-market purchase worth €15k in Ocera Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to 14159 capital (GP), LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations605 total
430 shares@ US$1.8858Common StockSEC:0001144204-12-014963:0
Canonical exit: 10 Jun 2012 (T+90)
1,170 shares@ US$1.87Common StockSEC:0001144204-12-014963:1
Canonical exit: 10 Jun 2012 (T+90)
8,628 shares@ US$2.3396Common StockSEC:0001144204-12-014963:2
Canonical exit: 10 Jun 2012 (T+90)
15,076 shares@ US$2.55Common StockSEC:0001144204-12-014963:3
Canonical exit: 10 Jun 2012 (T+90)
4,186 shares@ US$2.9581Common StockSEC:0001144204-12-014963:4
Canonical exit: 11 Jun 2012 (T+90)
1,482 shares@ US$2.9891Common StockSEC:0001144204-12-014963:5
Canonical exit: 12 Jun 2012 (T+90)
910 shares@ US$3.0055Common StockSEC:0001144204-12-014963:6
Canonical exit: 12 Jun 2012 (T+90)
583 shares@ US$29.8792Common StockSEC:0001144204-12-014100:0
Canonical exit: 5 Jun 2012 (T+90)
516 shares@ US$30.3638Common StockSEC:0001144204-12-014100:1
Canonical exit: 6 Jun 2012 (T+90)
405 shares@ US$29.4704Common StockSEC:0001144204-12-013005:0
Canonical exit: 30 May 2012 (T+90)
2,419 shares@ US$29.5205Common StockSEC:0001144204-12-013005:1
Canonical exit: 31 May 2012 (T+90)
2,254 shares@ US$29.9561Common StockSEC:0001144204-12-013005:2
Canonical exit: 3 Jun 2012 (T+90)
1,845 shares@ US$30.0688Common StockSEC:0001144204-12-013005:3
Canonical exit: 3 Jun 2012 (T+90)
974 shares@ US$29.0306Common StockSEC:0001144204-12-012153:0
Canonical exit: 27 May 2012 (T+90)
1,353 shares@ US$29.1085Common StockSEC:0001144204-12-012153:1
Canonical exit: 28 May 2012 (T+90)
4,149 shares@ US$29.0581Common StockSEC:0001144204-12-012153:2
Canonical exit: 29 May 2012 (T+90)
1,238 shares@ US$27.9769Common StockSEC:0001144204-12-010671:0
Canonical exit: 21 May 2012 (T+90)
145 shares@ US$27.9811Common StockSEC:0001144204-12-010671:1
Canonical exit: 22 May 2012 (T+90)
1,639 shares@ US$28.1238Common StockSEC:0001144204-12-010671:2
Canonical exit: 23 May 2012 (T+90)
1,475 shares@ US$28.437Common StockSEC:0001144204-12-009723:0
Canonical exit: 14 May 2012 (T+90)
849 shares@ US$28.8772Common StockSEC:0001144204-12-009723:1
Canonical exit: 15 May 2012 (T+90)
10 shares@ US$28.9625Common StockSEC:0001144204-12-009723:2
Canonical exit: 16 May 2012 (T+90)
2,460 shares@ US$29.6106Common StockSEC:0001144204-12-009723:3
Canonical exit: 16 May 2012 (T+90)
2,419 shares@ US$29.8548Common StockSEC:0001144204-12-009723:4
Canonical exit: 16 May 2012 (T+90)
161 shares@ US$26.1651Common StockSEC:0001144204-12-007401:0
Canonical exit: 8 May 2012 (T+90)
25 of 605 declarations
